Edwards Lifesciences patient monitoring logo

Engineered for critical-care teams. Audited under ISO 13485 & IEC 60601-1.

Critical care monitoring station with waveform displays
Patient monitoring & remote care

Edwards Lifesciences monitoring built for bedside decisions

Plan hemodynamic platforms, SpO2 accuracy workflows, telemetry stations, and remote observation paths with documentation that procurement, biomed, and clinical leaders can audit together.

FDA cleared*where 510(k) applicable
CE MDR2017/745 pathway
ISO 13485QMS audited
HL7 FHIRobservation-ready

*Use “FDA cleared” for 510(k) devices. PMA products follow separate labeling. Confirm model-specific status in current IFU and GUDID records.

IEC 60601-1electrical safety baseline
IEC 60601-1-8alarm priority design
UDI / GUDIDtraceable device IDs
4h / 24hurban / rural FSE target
50+countries service coverage
Monitoring heritage checkpoints

From catheter-era insight to connected observation

Milestones are due-diligence anchors for value-analysis teams. Corroborate historical and model-specific records in public filings, labeling, and regulatory databases.

Catheter monitoring roots

Early hemodynamic thinking established bedside pressure and flow observation as a clinical decision layer, not only a charting task.

Critical-care platform era

Hospital programs consolidated multiparameter monitoring, alarm governance, and nursing-station telemetry into formal capital planning.

Connected care expansion

HL7 messaging, EMR observation feeds, and remote review paths became standard evaluation criteria alongside SpO2 accuracy and MTBF.

MDR transition planning

European programs mapped CE marking under MDR 2017/745, PMS plans, and vigilance reporting into procurement checklists.

Cybersecurity SBOM focus

Premarket cybersecurity guidance and software bill of materials disclosure entered RFP and hospital IT security reviews.

Local verification remains model-specific

Current decisions still depend on exact sensor family, software revision, alarm profile, intended use, and site acceptance criteria.

Care settings

Start with the care environment, not a SKU

“We evaluate monitoring platforms by alarm priority design, SpO2 accuracy under motion, FHIR observation reliability, and the hours it takes biomed to restore a failed bed—not by brochure adjectives.”

Evidence principle for value-analysis teams — illustrative composite role and care setting, not a customer endorsement
Planning envelopes

Make four assumptions explicit before configuration

99.5%uptime planning target*
2.4havg MTTR planning band*
±2%SpO2 accuracy discussion band*
HL7/FHIRintegration checklist items

*Planning envelopes for procurement conversations, not guaranteed site performance. Confirm exact values in model-specific documentation and local verification records.

Bring your bed count, alarm policy, and interface map

We will structure a product, service, and capability conversation without treating nominal brochure metrics as guaranteed outcomes.